Continuous Glucose Monitoring (CGM) System Market By Product Type (Sensors, Transmitters, Receivers), By Technology (Real-Time Continuous Glucose Monitoring (rtCGM), Flash Glucose Monitoring (FGM)), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Age Group (Pediatric Patients, Adult Population, Geriatric Population), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End-user (Hospitals & Clinics, Diagnostic Centers, Homecare Settings, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Product Type

• Sensors
• Transmitters
• Receivers

By Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

By Technology

• Real-Time Continuous Glucose Monitoring (rtCGM)
• Flash Glucose Monitoring (FGM)

By Age Group

• Pediatric Patients
• Adult Population
• Geriatric Population

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online

By End User

• Hospitals & Clinics
• Diagnostic Centers
• Homecare Settings
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Abbott Laboratories
• Dexcom, Inc.
• Medtronic plc
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Novo Nordisk
• Senseonics Holdings, Inc.
• A. Menarini Diagnostics
• Bayer AG
• GE Healthcare
• Insulet Corporation
• LifeScan
• Ypsomed AG
• GlySens Incorporated
• Microchip Technology Inc.
• STMicroelectronics
• Medtrum Technologies, Inc.
• Nemaura Medical, Inc.
• Signos, Inc.
• Qualcomm